ADMA Biologics Inc.

NASDAQ: ADMA · Real-Time Price · USD
16.95
-0.02 (-0.12%)
At close: Aug 15, 2025, 3:59 PM
17.00
0.29%
After-hours: Aug 15, 2025, 07:08 PM EDT

ADMA Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
34.22M 26.9M 111.9M 35.91M 32.06M 17.81M -17.64M 2.57M -6.37M -6.79M -12.23M -14.9M -13.76M -25.01M -16.65M -17.71M -18.91M -18.38M
Depreciation & Amortization
2.06M 1.97M 1.94M 1.94M 2.05M 2.11M 2.11M 2.09M 2.1M 2.03M 1.94M 1.86M 1.72M 1.59M 1.52M 1.42M 1.33M 1.23M
Stock-Based Compensation
4.96M 4.62M 5.43M 3.18M 2.86M 2.14M 1.75M 1.69M 1.64M 1.11M 1.07M 1.31M 1.19M 1.64M 1.21M 688.27K 805.19K 781.4K
Other Working Capital
n/a -5.53M 8.07M -5.82M -7.09M 2.06M 4.5M -204.72K 3.82M -535.67K 6.93M 1.56M -423.54K -1.67M 3.48M 1.89M 3.73M -3.61M
Other Non-Cash Items
-21.72M 154K -82.78M 224K 193K 33.19M 34.65M 1.68M 1.64M 1.45M 1.85M 1.93M 1.35M 7.22M 467.52K 450.28K 428.65K 408.09K
Deferred Income Tax
1.62M 3.42M n/a n/a n/a n/a -6.86M 92.85K n/a n/a n/a n/a n/a n/a 140.28K 2.34K 77.35K 781.00
Change in Working Capital
n/a -56.75M 13.72M -16.22M 8.48M -24.52M 3.6M 3.86M -5.06M -12.53M -2.89K -3.49M -3.33M -11.46M -20.15M 1.74M -15.99M -17.27M
Operating Cash Flow
21.14M -19.68M 50.22M 25.03M 45.65M -2.22M 17.6M 11.99M -6.06M -14.72M -7.38M -13.28M -12.83M -26.01M -33.47M -13.41M -32.26M -33.23M
Capital Expenditures
-2.42M -4.7M -2.75M -742K -2.37M -2.36M -1.41M -756.56K -872.63K -1.94M -3.75M -3.38M -3.94M -2.84M -3.68M -2.79M -4.48M -2.57M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-105K -19K 7K -356K n/a -15K -210K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-2.53M -4.72M -2.75M -1.1M -2.37M -2.36M -1.41M -756.56K -872.63K -1.94M -3.75M -3.38M -3.94M -2.84M -3.68M -2.79M -4.48M -2.57M
Debt Repayment
n/a n/a -30M -30M n/a n/a -23.58M n/a -6.46K -10K -9.4K -9.25K -9.09K 51.74M -8.79K -8.65K -8.5K -8.36K
Common Stock Repurchased
n/a n/a n/a 3.17M -693K -2.48M n/a -208.64K n/a -640.95K n/a -429.98K -309.95K -91.37K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
48K -7.13M -644K 4.53M -362K -1.45M -15.07M 415.36K -224.97K -640.51K -1.89M -404.56K -309.95K -4.47M 53.83M -2.29K n/a -59.31K
Financial Cash Flow
48K -7.13M -31.03M -25.47M -362K -1.45M -38.99M 415.36K 240.12K -650.51K 62.74M -843.79K -319.04K 47.27M 53.82M 8.2M 17.18M 41.84M
Net Cash Flow
18.66M -31.52M 16.44M -1.54M 42.92M -6.03M -22.8M 11.64M -6.69M -17.32M 51.62M -17.51M -17.09M 18.42M 16.68M -8M -19.56M 6.04M
Free Cash Flow
18.72M -24.38M 47.47M 24.29M 43.28M -4.58M 16.19M 11.23M -6.93M -16.67M -11.13M -16.67M -16.77M -28.86M -37.14M -16.2M -36.74M -35.8M